Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT01857492

tDCS for the Management of Chronic Visceral Pain in Patients With Chronic Pancreatitis

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Beth Israel Deaconess Medical Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study is testing whether the addition of a noninvasive form of brain stimulation called transcranial direct current stimulation (tDCS) when combined with meditation helps decrease the abdominal pain in patients with chronic pancreatitis. The device involved in this study, transcranial direct current stimulation (tDCS) is investigational. This means that the study device is still being tested in research studies and is not approved by the Food and Drug Administration \[FDA\].

Detailed description

This is a double-blind, pilot study with the goal of testing the effects of tDCS coupled with meditation in the management of visceral pain in patients with chronic pancreatitis. We will enroll a total of 14 subjects with chronic pancreatitis. After enrollment, subjects will be randomized to active stimulation plus mediation (7 subjects) or sham stimulation plus meditation (7 subjects). Subjects will undergo 5 days of active tDCS stimulation plus meditation or sham tDCS plus meditation. Sessions will last approximately 30 min - 1 hour. EEG activity will be measured in the first, last and follow-up visits. After each stimulation session, we will assess for adverse effects using the tDCS adverse effects questionnaire. We will also have the subject fill out a pain/medication diary during the 5 days of treatment. All study procedures will be completed at BIDMC.

Conditions

Interventions

TypeNameDescription
DEVICEtDCS
BEHAVIORALMeditationBoth Active and SHAM groups will receive Meditation.

Timeline

Start date
2013-03-01
Primary completion
2014-01-01
Completion
2014-01-01
First posted
2013-05-20
Last updated
2015-03-11

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01857492. Inclusion in this directory is not an endorsement.